Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

George Bakris

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Geographic Areas

United States

Physiology

Disease Progression

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
30
Sarafidis, Pantelis
22
Sowers, James
17
Weir, Matthew
16
Wright, Jackson
14
Messerli, Franz
11
McCullough, Peter
10
Neutel, Joel
9
Jamerson, Kenneth
9
Weber, Michael
8
Phillips, Robert
8
Bell, David
8
Norris, Keith
7
Katholi, Richard
7
Davidai, Giora
7
Fonseca, Vivian

Sign-in to see all Coauthors

Publications

TOP 3
Kalaitzidis Rigas G; Bakris George L
The Current State of RAAS Blockade in the Treatment of Hypertension and Proteinuria.
Roberts William C; Bakris George L; Black Henry R; Sica Domenic A; Sulkes Destry J
The editor's roundtable: prehypertension.
Bakris George L
The future of blood pressure control in a population with a growing girth.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of George Bakris (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Kalaitzidis Rigas G; Bakris George L
The Current State of RAAS Blockade in the Treatment of Hypertension and Proteinuria.
Current cardiology reports 2009;11(6):436-42.
2009: Roberts William C; Bakris George L; Black Henry R; Sica Domenic A; Sulkes Destry J
The editor's roundtable: prehypertension.
The American journal of cardiology 2009;104(8):1105-15.
2009: Bakris George L
The future of blood pressure control in a population with a growing girth.
Current opinion in nephrology and hypertension 2009;18(5):379-80.
2009: Kalaitzidis Rigas G; Bakris George L
Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?
Current opinion in nephrology and hypertension 2009;18(5):386-91.
2009: Bakris George L; Kuritzky Louis
Monitoring and managing urinary albumin excretion: practical advice for primary care clinicians.
Postgraduate medicine 2009;121(4):51-60.
2009: Kalaitzidis Rigas; Bakris George L
Effects of angiotensin II receptor blockers on diabetic nephropathy.
Journal of hypertension 2009;27 Suppl 5():S15-21.
2009: Kalaitzidis Rigas; Bakris George L
Lower blood pressure goals for cardiovascular and renal risk reduction: are they defensible?
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(7):345-7.
2009: Dronovalli Suma; Burney Basil O; Bakris George L
Glycemic control and cardiovascular disease in chronic kidney disease.
Current diabetes reports 2009;9(3):243-8.
2009: Bakris George L; Fonseca Vivian A; Sharma Kumar; Wright Ernest M
Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications.
Kidney international 2009;75(12):1272-7.
2009: Sarafidis Pantelis A; Bakris George L
Does evidence support renin-angiotensin system blockade for slowing nephropathy progression in elderly persons?
Annals of internal medicine 2009;150(10):731-3.
2009: Khosla Nitin; Kalaitzidis Rigas; Bakris George L
The kidney, hypertension, and remaining challenges.
The Medical clinics of North America 2009;93(3):697-715, Table of Contents.
2009: Zanchetti Alberto; Mancia Giuseppe; Black Henry R; Oparil Suzanne; Waeber Bernard; Schmieder Roland E; Bakris George L; Messerli Franz H; Kjeldsen Sverre E; Ruilope Luis M
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.
Journal of hypertension 2009;27(4):673-9.
2009: Bakris George L; Ritz Eberhard;
Hypertension: the message of World Kidney Day 2009.
Nature reviews. Nephrology 2009;5(4):188-90.
2009: Bhuriya Rohit; Li Suying; Chen Shu-Cheng; McCullough Peter A; Bakris George L
Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;53(4 Suppl 4):S3-10.
2009: Kalaitzidis Rigas; Li Suying; Wang Changchun; Chen Shu-Cheng; McCullough Peter A; Bakris George L
Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP).
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;53(4 Suppl 4):S22-31.
2009: Whaley-Connell Adam; Sowers James R; McCullough Peter A; Roberts Tricia; McFarlane Samy I; Chen Shu-Cheng; Li Suying; Wang Changchun; Collins Allan J; Bakris George L;
Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;53(4 Suppl 4):S11-21.
2009: Bakris George L; McCullough Peter A; Collins Allan J
Executive summary: Kidney Early Evaluation Program (KEEP) 2008 annual data report.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;53(4 Suppl 4):S1-2.
2009: Burney Basil O; Kalaitzidis Rigas G; Bakris George L
Novel therapies of diabetic nephropathy.
Current opinion in nephrology and hypertension 2009;18(2):107-11.
2009: Bakris George L; Ritz Eberhard;
The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(3):144-7.
2009: Bakris George L; Ritz Eberhard;
The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented.
Journal of hypertension 2009;27(3):666-9.
2009: Bakris George L; Ritz Eberhard
World Kidney Day 2009: hypertension and kidney disease is a marriage that should be prevented.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;53(3):373-6.
2009: Bakris George L; Ritz Eberhard;
The message for World Kidney Day 2009: Hypertension and kidney disease: a marriage that should be prevented.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(3):695-7.
2009: Bakris George L; Ritz Eberhard
The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented.
Kidney international 2009;75(5):449-52.
2009: Bakris George L; Ritz Eberhard;
The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(3):517-9.
2009: Bakris G L; Ritz E;
The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented.
Journal of human hypertension 2009;23(3):222-5.
2009: Hopkins Keith; Bakris George L
Assessing blood pressure control in dialysis patients: finally a step forward.
Hypertension 2009;53(3):448-9.
2009: Bakris George L; Ritz Eberhard
The message for World Kidney Day 2009: hypertension and kidney disease-a marriage that should be prevented.
Pediatric nephrology (Berlin, Germany) 2009;24(3):427-30.
2009: Bhatnagar Vibha; O'Connor Daniel T; Brophy Victoria H; Schork Nicholas J; Richard Erin; Salem Rany M; Nievergelt Caroline M; Bakris George L; Middleton John P; Norris Keith C; Wright Jackson; Hiremath Leena; Contreras Gabriel; Appel Lawrence J; Lipkowitz Michael S;
G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.
American journal of hypertension 2009;22(3):332-8.
2009: Bakris George L; Ritz Eberhard
The message for World Kidney Day 2009: Hypertension and kidney disease: a marriage that should be prevented.
Nephrology (Carlton, Vic.) 2009;14(1):49-51.
2009: Bakris George L; Ritz Eberhard;
Hypertension and kidney disease: a combination that should be prevented.
Nephrology news & issues 2009;23(2):42, 44, 46.
2009: Bakris George L; Ritz Eberhard;
The message for World Kidney Day 2009: hypertension and kidney disease-a marriage that should be prevented.
Clinical and experimental nephrology 2009;13(1):96-9.
2009: Bakris George L; Ritz Eberhard;
The message for World Kidney Day 2009: hypertension and kidney disease, a marriage that should be prevented.
Iranian journal of kidney diseases 2009;3(1):7-10.
2009: Bakris George L; Ritz Eberhard;
The message for World Kidney Day 2009: Hypertension and kidney disease: a marriage that should be prevented.
Archives of Iranian medicine 2009;12(1):102-5.
2009: Bakris George L; Ritz Eberhard;
The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented.
American journal of nephrology 2009;30(1):95-8.
2009: Bakris George L; Ritz Eberhard;
The message for World Kidney Day 2009. Hypertension and kidney disease: a marriage that should be prevented.
Nephron. Clinical practice 2009;111(2):c155-8.
2009: Bakris George L; Ritz Eberhard
The message for World Kidney Day 2009: Hypertension and kidney disease: a marriage that should be prevented.
Kidney & blood pressure research 2009;32(1):67-70.
2009: Bakris George L; Ritz Eberhard;
The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented.
Blood purification 2009;27(2):231-4.
2009: Kalaitzidis Rigas G; Sarafidis Pantelis A; Bakris George L
Effects of thiazolidinediones beyond glycaemic control.
Current pharmaceutical design 2009;15(5):529-36.
2008: Jamerson Kenneth; Weber Michael A; Bakris George L; Dahlöf Björn; Pitt Bertram; Shi Victor; Hester Allen; Gupte Jitendra; Gatlin Marjorie; Velazquez Eric J;
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
The New England journal of medicine 2008;359(23):2417-28.
2008: Dronavalli Suma; Bakris George L
Mechanistic insights into diuretic-induced insulin resistance.
Hypertension 2008;52(6):1009-11.
2008: Sarafidis Pantelis A; Bakris George L
Resistant hypertension: an overview of evaluation and treatment.
Journal of the American College of Cardiology 2008;52(22):1749-57.
2008: Bakris George L
Albuminuria reduction and nephropathy progression.
Current hypertension reports 2008;10(5):388-9.
2008: Bakris George L
Should a lower blood pressure goal and albuminuria reduction be mandated to slow hypertensive nephropathy?
Current hypertension reports 2008;10(5):387-8.
2008: Blankstein Ron; Bakris George L
Changes in kidney function following heart failure treatment: focus on renin-angiotensin system blockade.
Heart failure clinics 2008;4(4):425-38.
2008: Blankstein Ron; Bakris George L
Renal hemodynamic changes in heart failure.
Heart failure clinics 2008;4(4):411-23.
2008: Bakris George L; Sowers James R;
ASH position paper: treatment of hypertension in patients with diabetes-an update.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(9):707-13; discussion 714-5.
2008: Sarafidis Pantelis A; Bakris George L
Renin-angiotensin blockade and kidney disease.
Lancet 2008;372(9638):511-2.
2008: McCullough Peter A; Li Suying; Jurkovitz Claudine T; Stevens Leslie; Collins Alan J; Chen Shu-Cheng; Norris Keith C; McFarlane Samy; Johnson Bruce; Shlipak Michael G; Obialo Chamberlain I; Brown Wendy W; Vassalotti Joseph; Whaley-Connell Adam T; Brenner Robert M; Bakris George L;
Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
American heart journal 2008;156(2):277-83.
2008: Saab Georges; Whaley-Connell Adam T; McCullough Peter A; Bakris George L
CKD awareness in the United States: the Kidney Early Evaluation Program (KEEP).
American journal of kidney diseases : the official journal of the National Kidney Foundation 2008;52(2):382-3.
2008: Dronavalli Suma; Duka Irena; Bakris George L
The pathogenesis of diabetic nephropathy.
Nature clinical practice. Endocrinology & metabolism 2008;4(8):444-52.
2008: Vasisht K P; Bakris G
New onset diabetes: can it be delayed?
Journal of human hypertension 2008;22(8):517-9.
2008: Bakris George; Burgess Ellen; Weir Matthew; Davidai Giora; Koval Stephen;
Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy.
Kidney international 2008;74(3):364-9.
2008: Carter Barry L; Einhorn Paula T; Brands Michael; He Jiang; Cutler Jeffrey A; Whelton Paul K; Bakris George L; Brancati Frederick L; Cushman William C; Oparil Suzanne; Wright Jackson T;
Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute.
Hypertension 2008;52(1):30-6.
2008: Bakris G L; Toto R D; McCullough P A; Rocha R; Purkayastha D; Davis P;
Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
Kidney international 2008;73(11):1303-9.
2008: Gradman Alan H; Weir Matthew R; Bakris George L
Newer combination therapies in the management of hypertension: an update.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(5):398-405.
2008: Bakris George L; Weir Matthew R
Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
Postgraduate medicine 2008;120(1):33-42.
2008: Appel Lawrence J; Wright Jackson T; Greene Tom; Kusek John W; Lewis Julia B; Wang Xuelei; Lipkowitz Michael S; Norris Keith C; Bakris George L; Rahman Mahboob; Contreras Gabriel; Rostand Stephen G; Kopple Joel D; Gabbai Francis B; Schulman Gerald I; Gassman Jennifer J; Charleston Jeanne; Agodoa Lawrence Y;
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.
Archives of internal medicine 2008;168(8):832-9.
2008: Sarafidis Pantelis A; Li Suying; Chen Shu-Cheng; Collins Allan J; Brown Wendy W; Klag Michael J; Bakris George L
Hypertension awareness, treatment, and control in chronic kidney disease.
The American journal of medicine 2008;121(4):332-40.
2008: Astor B C; Yi S; Hiremath L; Corbin T; Pogue V; Wilkening B; Peterson G; Lewis J; Lash J P; Van Lente F; Gassman J; Wang X; Bakris G; Appel L J; Contreras G
N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK).
Circulation 2008;117(13):1685-92.
2008: McFarlane Samy I; Chen Shu-Cheng; Whaley-Connell Adam T; Sowers James R; Vassalotti Joseph A; Salifu Moro O; Li Suying; Wang Changchun; Bakris George; McCullough Peter A; Collins Allan J; Norris Keith C;
Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2008;51(4 Suppl 2):S46-55.
2008: Rao Madhav V; Qiu Yang; Wang Changchun; Bakris George
Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2008;51(4 Suppl 2):S30-7.
2008: Bakris George; Collins Allan J
Executive summary: Kidney Early Evaluation Program (KEEP) 2007 Annual Data Report.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2008;51(4 Suppl 2):S1-2.
2008: Weber Michael A; Bakris George L; Giles Thomas D; Messerli Franz H
Beta-blockers in the treatment of hypertension: new data, new directions.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(3):234-8.
2008: Bakris George L; Berkwits Michael
Trials that matter: the effect of a fixed-dose combination of an Angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes.
Annals of internal medicine 2008;148(5):400-1.
2008: Li S; Chen S-C; Shlipak M; Bakris G; McCullough P A; Sowers J; Stevens L; Jurkovitz C; McFarlane S; Norris K; Vassalotti J; Klag M J; Brown W W; Narva A; Calhoun D; Johnson B; Obialo C; Whaley-Connell A; Becker B; Collins A J;
Low birth weight is associated with chronic kidney disease only in men.
Kidney international 2008;73(5):637-42.
2008: Sarafidis Pantelis; Bogojevic Zvezdana; Basta Emad; Kirstner Emily; Bakris George L
Comparative efficacy of two different beta-blockers on 24-hour blood pressure control.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(2):112-8.
2008: Weir Matthew R; Bakris George L
Combination therapy with Renin-Angiotensin-aldosterone receptor blockers for hypertension: how far have we come?
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(2):146-52.
2008: Sarafidis Pantelis A; Bakris George L
State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(2):130-9.
2008: Giles Thomas D; Bakris George L; Weber Michael A
Beta-blocker therapy in hypertension: a need to pause and reflect.
Journal of the American College of Cardiology 2008;51(4):516-7; author reply 517-8.
2008: Bakris George L
Slowing nephropathy progression: focus on proteinuria reduction.
Clinical journal of the American Society of Nephrology : CJASN 2008;3 Suppl 1():S3-10.
2008: Bakris George L
Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(1 Suppl 1):27-32.
2008: Cushman William C; Neutel Joel M; Saunders Elijah; Bakris George L; Ferdinand Keith C; Ofili Elizabeth O; Sowers James R; Madder Robert; Weber Michael A
Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy.
The American journal of geriatric cardiology 2008;17(1):27-36.
2008: Bakris G; Hill M; Mancia G; Steyn K; Black H R; Pickering T; De Geest S; Ruilope L; Giles T D; Morgan T; Kjeldsen S; Schiffrin E L; Coenen A; Mulrow P; Loh A; Mensah G
Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action.
Journal of human hypertension 2008;22(1):63-70.
2008: Phillips Robert A; Fonseca Vivian; Katholi Richard E; McGill Janet B; Messerli Franz H; Bell David S H; Raskin Philip; Wright Jackson T; Iyengar Malini; Anderson Karen M; Lukas Mary Ann; Bakris George L;
Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.
Journal of the cardiometabolic syndrome 2008;3(4):211-7.
2008: Bakris George L; Weber Michael A
Appropriate dose transition to a controlled-release formulation of carvedilol in patients with hypertension.
Reviews in cardiovascular medicine 2008;9(2):96-105.
2008: Kjeldsen Sverre E; Jamerson Kenneth A; Bakris George L; Pitt Bertram; Dahlöf Björn; Velazquez Eric J; Gupte Jitendra; Staikos Linda; Hua Tsushung A; Shi Victor; Hester Allen; Tuomilehto Jaakko; Ostergren Jan; Ibsen Hans; Weber Michael;
Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.
Blood pressure 2008;17(1):7-17.
2008: Bakris George; Fonseca Vivian; Foody JoAnne
Challenges to the diagnosis, evaluation, treatment, and management of clustered cardiometabolic risk factors.
Journal of the cardiometabolic syndrome 2008;3(2):119-25.
2008: Bakris George; Molitch Mark; Zhou Qian; Sarafidis Pantelis; Champion Annette; Bacher Peter; Sowers James R
Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: results of the STAR-LET study.
Journal of the cardiometabolic syndrome 2008;3(1):18-25.
2008: Bakris George L; Sowers James R; Ferdinand Keith C
Blood pressure control in the patient with difficult-to-control hypertension: which agent for which patient?
Preventive cardiology 2008;11(1):42-9.
2008: Sarafidis Pantelis A; Riehle Jessica; Bogojevic Zvezdana; Basta Emad; Chugh Atul; Bakris George L
A comparative evaluation of various methods for microalbuminuria screening.
American journal of nephrology 2008;28(2):324-9.
2007: Bakris George L
Lifestyle changes and unanswered questions about hypertension and cardiovascular risk.
Current hypertension reports 2007;9(5):392.
2007: Stafylas P C; Sarafidis P A; Lasaridis A N; Tsakni E; Niakas D A; Dombros N V; Grekas D M; Bakris G L
Cost-effectiveness of losartan in diabetic nephropathy: a Greek perspective.
Journal of nephrology 2007;20(6):703-15.
2007: Wright Jackson T; Bakris George L; Bell David S H; Fonseca Vivian; Katholi Richard E; McGill Janet B; Messerli Franz H; Phillips Robert A; Raskin Philip; Holdbrook Fred K; Lukas Mary Ann; Iyengar Malini
Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(11):842-9.
2007: Black Henry R; Bakris George L; Weber Michael A; Weiss Robert; Shahawy Mahfouz El; Marple Richard; Tannoury Georges; Linas Stuart; Wiens Brian L; Linseman Jennifer V; Roden Robert; Gerber Michael J
Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(10):760-9.
2007: Bhatnagar Vibha; O'Connor Daniel T; Schork Nicholas J; Salem Rany M; Nievergelt Caroline M; Rana Brinda K; Smith Douglas W; Bakris George L; Middleton John P; Norris Keith C; Wright Jackson T; Cheek Deanna; Hiremath Leena; Contreras Gabriel; Appel Lawrence J; Lipkowitz Michael S
Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.
Journal of hypertension 2007;25(10):2082-92.
2007: Bakris G L; Ruilope L; Locatelli F; Ptaszynska A; Pieske B; de Champlain J; Weber M A; Raz I
Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial.
Kidney international 2007;72(7):879-85.
2007: Duka Irena; Bakris George L
Should all patients with type 2 diabetes receive initial combination therapy: an assessment of the ADVANCE trial.
Polskie archiwum medycyny wewn?trznej 2007;117(9):389-90.
2007: Hart Peter D; Bakris George L
Should beta-blockers be used to control hypertension in people with chronic kidney disease?
Seminars in nephrology 2007;27(5):555-64.
2007: Chugh Atul; Bakris George L
Pulse pressure and arterial stiffness: an emerging renal risk predictor?
Journal of hypertension 2007;25(9):1796-7.
2007: Sarafidis P A; Lasaridis A N; Nilsson P M; Pikilidou M I; Stafilas P C; Kanaki A; Kazakos K; Yovos J; Bakris G L
Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes.
Journal of human hypertension 2007;21(9):709-16.
2007: Mancia Giuseppe; Messerli Franz; Bakris George; Zhou Qian; Champion Annette; Pepine Carl J
Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study.
Hypertension 2007;50(2):299-305.
2007: Bakris George L
Protein kinase C-beta inhibition: a promise not yet fulfilled.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(4):619-20.
2007: Roberts William C; Black Henry R; Bakris George L; Mason R Preston; Giles Thomas D; Sulkes Destry J
The editor's roundtable: revisiting the role of beta blockers in hypertension.
The American journal of cardiology 2007;100(2):253-67.
2007: Messerli Franz H; Bell David S H; Fonseca Vivian; Katholi Richard E; McGill Janet B; Phillips Robert A; Raskin Philip; Wright Jackson T; Bangalore Sripal; Holdbrook Fred K; Lukas Mary Ann; Anderson Karen M; Bakris George L;
Body weight changes with beta-blocker use: results from GEMINI.
The American journal of medicine 2007;120(7):610-5.
2007: Fonseca V; Bakris G L; Bell D S H; McGill J B; Raskin P; Messerli F H; Phillips R A; Katholi R E; Wright J T; Waterhouse B; Lukas M A; Anderson K M;
Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.
Diabetic medicine : a journal of the British Diabetic Association 2007;24(7):759-63.
2007: Bakris George L
Current perspectives on hypertension and metabolic syndrome.
Journal of managed care pharmacy : JMCP 2007;13(5 Suppl):S3-5.
2007: Bakris George L; Gonzalez Edgar R
Case study: the link between hypertension and diabetes.
Journal of managed care pharmacy : JMCP 2007;13(5 Suppl):S17-9.
2007: Bakris George L
Pharmacological augmentation of endothelium-derived nitric oxide synthesis.
Journal of managed care pharmacy : JMCP 2007;13(5 Suppl):S9-12.
2007: McCullough Peter A; Jurkovitz Claudine T; Pergola Pablo E; McGill Janet B; Brown Wendy W; Collins Alan J; Chen Shu-Cheng; Li Suying; Singh Ajay; Norris Keith C; Klag Michael J; Bakris George L;
Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP).
Archives of internal medicine 2007;167(11):1122-9.
2007: Sarafidis Pantelis A; McFarlane Samy I; Bakris George L
Antihypertensive agents, insulin sensitivity, and new-onset diabetes.
Current diabetes reports 2007;7(3):191-9.
2007: Bakris George L
ACE inhibitors and ARBs: are they better than other agents to slow nephropathy progression?
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(6):413-5.
2007: Smith Timothy R; Philipp Thomas; Vaisse Bernard; Bakris George L; Wernsing Margaret; Yen Joseph; Glazer Robert
Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(5):355-64.
2007: McGill J B; Bakris G L; Fonseca V; Raskin P; Messerli F H; Phillips R A; Katholi R E; Wright J T; Iyengar M; Anderson K M; Lukas M A; Dalal M R; Bell D S H
beta-blocker use and diabetes symptom score: results from the GEMINI study.
Diabetes, obesity & metabolism 2007;9(3):408-17.
2007: Bakris G; Dickholtz M; Meyer P M; Kravitz G; Avery E; Miller M; Brown J; Woodfield C; Bell B
Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: a pilot study.
Journal of human hypertension 2007;21(5):347-52.
2007: Gilbert Richard E; Kim Sandra A; Tuttle Katherine R; Bakris George L; Toto Robert D; McGill Janet B; Haney Douglas J; Kelly Darren J; Anderson Pamela W
Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.
Diabetes care 2007;30(4):995-6.
2007: Chugh Atul; Bakris George L
Microalbuminuria: what is it? Why is it important? What should be done about it? An update.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(3):196-200.
2007: Bakris George L; Weir Matthew R; Black Henry R
Improving blood pressure control rates: is there more we can do?
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(2):134-42.
2007: Ahmed Ali; Rich Michael W; Sanders Paul W; Perry Gilbert J; Bakris George L; Zile Michael R; Love Thomas E; Aban Inmaculada B; Shlipak Michael G
Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study.
The American journal of cardiology 2007;99(3):393-8.
2007: Robinson Jennifer G; Bakris George; Torner James; Stone Neil J; Wallace Robert
Is it time for a cardiovascular primary prevention trial in the elderly?
Stroke; a journal of cerebral circulation 2007;38(2):441-50.
2007: Sarafidis Pantelis A; Bakris George L
Review: Insulin and endothelin: an interplay contributing to hypertension development?
The Journal of clinical endocrinology and metabolism 2007;92(2):379-85.
2007: Buse John B; Ginsberg Henry N; Bakris George L; Clark Nathaniel G; Costa Fernando; Eckel Robert; Fonseca Vivian; Gerstein Hertzel C; Grundy Scott; Nesto Richard W; Pignone Michael P; Plutzky Jorge; Porte Daniel; Redberg Rita; Stitzel Kimberly F; Stone Neil J;
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
Circulation 2007;115(1):114-26.
2007: Buse John B; Ginsberg Henry N; Bakris George L; Clark Nathaniel G; Costa Fernando; Eckel Robert; Fonseca Vivian; Gerstein Hertzel C; Grundy Scott; Nesto Richard W; Pignone Michael P; Plutzky Jorge; Porte Daniel; Redberg Rita; Stitzel Kimberly F; Stone Neil J;
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
Diabetes care 2007;30(1):162-72.
2007: Sarafidis Pantelis A; Khosla Nitin; Bakris George L
Antihypertensive therapy in the presence of proteinuria.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;49(1):12-26.
2007: Sarafidis Pantelis A; Bakris George L
Are antihypertensive drugs associated with an increased risk of incident type 2 diabetes?
Nature clinical practice. Endocrinology & metabolism 2007;3(1):8-9.
2007: Sarafidis Pantelis A; Bakris George L
Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents.
Journal of hypertension 2007;25(1):249-52; author reply 252-3.
2007: Sarafidis P A; Bakris G L
Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance?
Journal of human hypertension 2007;21(1):12-9.
2007: Bakris George L; Cooper-Dehoff Rhonda M; Zhou Qian; Kupfer Stuart; Champion Annette; Pepine Carl J;
Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2007;7 Suppl 1():25-9.
2007: Sowers James R; Bakris George L; Black Henry R; Giles Thomas D
The cardiometabolic syndrome and calcium channel blocker combination drugs.
Journal of the cardiometabolic syndrome 2007;2(3):207-12.
2007: Jamerson Kenneth; Bakris George L; Dahlöf Björn; Pitt Bertram; Velazquez Eric; Gupte Jitendra; Lefkowitz Martin; Hester Allen; Shi Victor; Kjeldsen Sverre E; Cushman William; Papademetriou Vasilios; Weber Michael;
Exceptional early blood pressure control rates: the ACCOMPLISH trial.
Blood pressure 2007;16(2):80-6.
2007: Ruilope Luis; Kjeldsen Sverre E; de la Sierra Alejandro; Mancia Giuseppe; Ruggenenti Piero; Stergiou George S; Bakris George L; Giles Thomas D
The kidney and cardiovascular risk--implications for management: a consensus statement from the European Society of Hypertension.
Blood pressure 2007;16(2):72-9.
2007: Weber Michael A; Bakris George L; Dahlöf Björn; Pitt Bertram; Velazquez Eric; Gupte Jitendra; Lefkowitz Martin; Hester Allen; Shi Victor; Weir Matthew; Kjeldsen Sverre; Massie Barry; Nesbitt Shawna; Ofili Elizabeth; Jamerson Kenneth
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk.
Blood pressure 2007;16(1):13-9.
2007: Sarafidis Pantelis A; Bakris George L
The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance?
American journal of nephrology 2007;27(1):44-54.
2006: Weber Michael A; Bakris George L; Tarka Elizabeth A; Iyengar Malini; Fleck Richard; Sica Domenic A
Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(12):840-9.
2006: Bakris George; Molitch Mark; Hewkin Ann; Kipnes Mark; Sarafidis Pantelis; Fakouhi Kaffa; Bacher Peter; Sowers James;
Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome.
Diabetes care 2006;29(12):2592-7.
2006: Bakris G L; Hart P; Ritz E
Beta blockers in the management of chronic kidney disease.
Kidney international 2006;70(11):1905-13.
2006: Bakris George L; Tarka Elizabeth A; Waterhouse Brian; Goulding Michelle R; Madan Anuradha; Anderson Karen M; St John Sutton Martin; Miller Alan B; Reichek Nathaniel
Cardiovascular risk factors in hypertension: rationale and design of studies to investigate the effects of controlled-release carvedilol on regression of left ventricular hypertrophy and lipid profile.
The American journal of cardiology 2006;98(7A):46L-52L.
2006: Weber Michael A; Sica Domenic A; Tarka Elizabeth A; Iyengar Malini; Fleck Richard; Bakris George L
Controlled-release carvedilol in the treatment of essential hypertension.
The American journal of cardiology 2006;98(7A):32L-38L.
2006: Cooper-Dehoff Rhonda; Cohen Jerome D; Bakris George L; Messerli Franz H; Erdine Serap; Hewkin Ann C; Kupfer Stuart; Pepine Carl J;
Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
The American journal of cardiology 2006;98(7):890-4.
2006: Bakris George
The continuum of blood pressure risk: when is the best time to intervene?
Current hypertension reports 2006;8(5):395-7.
2006: Bakris George L; Ruilope Luis M; McMorn Stephen O; Weston Wayde M; Heise Mark A; Freed Martin I; Porter Lisa E
Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria.
Journal of hypertension 2006;24(10):2047-55.
2006: Sarafidis P A; Bakris G L
Protection of the kidney by thiazolidinediones: an assessment from bench to bedside.
Kidney international 2006;70(7):1223-33.
2006: Khosla Nitin; Sarafidis Pantelis A; Bakris George L
Microalbuminuria.
Clinics in laboratory medicine 2006;26(3):635-53, vi-vii.
2006: Sarafidis Pantelis A; Bakris George L
Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(9):2366-74.
2006: Bakris G L; Ruilope L; Locatelli F; Ptaszynska A; Pieske B; Raz I; Voors A A; Dechamplain J; Weber M A
Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trial.
Journal of human hypertension 2006;20(9):693-700.
2006: Messerli Franz H; Bakris George L; Ferrera David; Houston Mark C; Petrella Robert J; Flack John M; Sun William; Lee EunMee; Neutel Joel M;
Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(8):571-81; quiz 582-3.
2006: Zillich Alan J; Garg Jay; Basu Sanjib; Bakris George L; Carter Barry L
Thiazide diuretics, potassium, and the development of diabetes: a quantitative review.
Hypertension 2006;48(2):219-24.
2006: Sowers James R; Neutel Joel M; Saunders Elijah; Bakris George L; Cushman William C; Ferdinand Keith C; Ofili Elizabeth O; Weber Michael A;
Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(7):470-80.
2006: Sarafidis P A; Bakris G L
Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control.
QJM : monthly journal of the Association of Physicians 2006;99(7):431-6.
2006: Sarafidis Pantelis A; McFarlane Samy I; Bakris George L
Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome.
Current diabetes reports 2006;6(3):219-24.
2006: Milchak J L; Carter B L; Ardery G; Black H R; Bakris G L; Jones D W; Kreiter C D
Development of explicit criteria to measure adherence to hypertension guidelines.
Journal of human hypertension 2006;20(6):426-33.
2006: Sarafidis Panteleimon A; Bakris George L
Do the metabolic effects of beta blockers make them leading or supporting antihypertensive agents in the treatment of hypertension?
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(5):351-6; quiz 357-8.
2006: Sarafidis Panteleimon A; Bakris George L
Antihypertensive therapy and the risk of new-onset diabetes.
Diabetes care 2006;29(5):1167-9.
2006: Ofili Elizabeth O; Ferdinand Keith C; Saunders Elijah; Neutel Joel M; Bakris George L; Cushman William C; Sowers James R; Weber Michael A
Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy.
Journal of the National Medical Association 2006;98(4):618-26.
2006: Weber Michael A; White William B; Giles Thomas D; Bakris George L; Neutel Joel M; Smith David Hg; Davidai Giora
An effectiveness study comparing algorithm-based antihypertensive therapy with previous treatments using conventional and ambulatory blood pressure measurements.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(4):241-50; quiz 251-2.
2006: Sarafidis Panteleimon A; Bakris George L
Are beta blockers passé for the treatment of hypertension?
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(4):239-40.
2006: Khosla Nitin; Bakris George
Lessons learned from recent hypertension trials about kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2006;1(2):229-35.
2006: Sarafidis Panteleimon A; Bakris George L
Level of kidney function determines cardiovascular fate after coronary bypass graft surgery.
Circulation 2006;113(8):1046-7.
2006: Bogojevic Zvezdana; Bakris George L
Albuminuria and cardiovascular risk.
Heart failure clinics 2006;2(1):53-9.
2006: White William B; Giles Thomas; Bakris George L; Neutel Joel M; Davidai Giora; Weber Michael A
Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting.
American heart journal 2006;151(1):176-84.
2006: Whaley-Connell Adam; Pavey Brian S; Afroze Aneesa; Bakris George L
Obesity and insulin resistance as risk factors for chronic kidney disease.
Journal of the cardiometabolic syndrome 2006;1(3):209-14; quiz 215-6.
2006: Sarafidis Pantelis A; Bakris George L
Insulin resistance, hyperinsulinemia, and hypertension: an epidemiologic approach.
Journal of the cardiometabolic syndrome 2006;1(5):334-42; quiz 343.
2006: Sarafidis Panteleimon A; Whaley-Connell Adam; Sowers James R; Bakris George L
Cardiometabolic syndrome and chronic kidney disease: what is the link?
Journal of the cardiometabolic syndrome 2006;1(1):58-65.
2006: Jones-Burton Charlotte; Mishra Shiraz I; Fink Jeffrey C; Brown Jeanine; Gossa Weyinshet; Bakris George L; Weir Matthew R
An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease.
American journal of nephrology 2006;26(3):268-75.
2006: Lim Hoong Sern; MacFadyen Robert J; Bakris George; Lip Gregory Y H
The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management.
Current pharmaceutical design 2006;12(13):1567-79.
2005: Bakris George L; Fonseca Vivian; Katholi Richard E; McGill Janet B; Messerli Franz; Phillips Robert A; Raskin Philip; Wright Jackson T; Waterhouse Brian; Lukas Mary Ann; Anderson Karen M; Bell David S H;
Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.
Hypertension 2005;46(6):1309-15.
2005: Tuttle Katherine R; Bakris George L; Toto Robert D; McGill Janet B; Hu Kuolung; Anderson Pamela W
The effect of ruboxistaurin on nephropathy in type 2 diabetes.
Diabetes care 2005;28(11):2686-90.
2005: Bakris George L; Smith David Hg; Giles Thomas D; White William B; Davidai Giora; Weber Michael A
Comparative antihypertensive efficacy of angiotensin receptor blocker-based treatment in African-American and white patients.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(10):587-95; quiz 596-7.
2005: Neutel Joel M; Saunders Elijah; Bakris George L; Cushman William C; Ferdinand Keith C; Ofili Elizabeth O; Sowers James R; Weber Michael A;
The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(10):578-86.
2005: Nathan Sandeep; Pepine Carl J; Bakris George L
Calcium antagonists: effects on cardio-renal risk in hypertensive patients.
Hypertension 2005;46(4):637-42.
2005: Mishra Shiraz I; Jones-Burton Charlotte; Fink Jeffrey C; Brown Jeanine; Bakris George L; Weir Matthew R
Does dietary salt increase the risk for progression of kidney disease?
Current hypertension reports 2005;7(5):385-91.
2005: Bakris George
Clinical trials report. Combination drug treatment for hypertension with nondiabetic renal disease.
Current hypertension reports 2005;7(5):358-9.
2005: Bakris George
Clinical trials report. Proteinuria and blood pressure reduction: are they of equal importance to preserve kidney function?
Current hypertension reports 2005;7(5):357-8.
2005: Bakris George
Proteinuria: a link to understanding changes in vascular compliance?
Hypertension 2005;46(3):473-4.
2005: Russo Christopher J; Melista Efthymia; Cui Jing; DeStefano Anita L; Bakris George L; Manolis Athanasios J; Gavras Haralambos; Baldwin Clinton T
Association of NEDD4L ubiquitin ligase with essential hypertension.
Hypertension 2005;46(3):488-91.
2005: Choi Kenneth L; Bakris George L
Hypertension treatment guidelines: practical implications.
Seminars in nephrology 2005;25(4):198-209.
2005: Garg Jay P; Ellis Renee; Elliott William J; Hasabou Nahla; Chua Dave; Chertow Glenn M; Bakris George L
Angiotensin receptor blockade and arterial compliance in chronic kidney disease: a pilot study.
American journal of nephrology 2005;25(4):393-9.
2005: Khosla Nitin; Chua Dave Y; Elliott William J; Bakris George L
Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications?
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(6):354-6.
2005: Preston Richard A; White William B; Pitt Bertram; Bakris George; Norris Paul M; Hanes Vladimir
Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.
American journal of hypertension 2005;18(6):797-804.
2005: White William B; Weber Michael A; Davidai Giora; Neutel Joel M; Bakris George L; Giles Thomas
Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial.
Blood pressure monitoring 2005;10(3):157-63.
2005: Bakris George
Is ethnicity a factor in choice of antihypertensive drug?
Postgraduate medicine 2005;117(5):40.
2005: Lea Janice; Greene Tom; Hebert Lee; Lipkowitz Michael; Massry Shaul; Middleton John; Rostand Stephen G; Miller Edgar; Smith Winifred; Bakris George L
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
Archives of internal medicine 2005;165(8):947-53.
2005: Bakris George L
Protecting renal function in the hypertensive patient: clinical guidelines.
American journal of hypertension 2005;18(4 Pt 2):112S-119S.
2005: Bakris George L
Preventing hypertensive kidney disease: the critical role of combination therapy.
American journal of hypertension 2005;18(4 Pt 2):93S-94S.
2005: El-Achkar Tarek M; Ohmit Suzanne E; McCullough Peter A; Crook Errol D; Brown Wendy W; Grimm Richard; Bakris George L; Keane William F; Flack John M;
Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program.
Kidney international 2005;67(4):1483-8.
2005: Bakris George
George Bakris, MD: researching ways to combat hypertension. Interview by Mike Mitka.
JAMA : the journal of the American Medical Association 2005;293(12):1439.
2005: Bakris George L; Bell David S H; Fonseca Vivian; Katholi Richard; McGill Janet; Phillips Robert; Raskin Philip; Wright Jackson T; Iyengar Malini; Holeslaw Terry; Anderson Karen M;
The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.
Journal of diabetes and its complications 2005;19(2):74-9.
2005: McFarlane Samy I; Castro Jonathan; Kaur Jasjeet; Shin John J; Kelling Douglas; Farag Amal; Simon Nicole; El-Atat Fadi; Sacerdote Alan; Basta Emad; Flack John; Bakris George; Sowers James R
Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(2):73-80.
2005: Bakris G L; Toto R D; McCullough P A
Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
Journal of human hypertension 2005;19(2):139-44.
2005: Bakris George L
ACE inhibitor for a diabetic patient with normal blood pressure?
Postgraduate medicine 2005;117(1):6.
2005: Drexler Andrew J; Nesto Richard W; Abrahamson Martin J; Bakris George; Bell David; Brunzell John; Dandona Paresh; Davidson Jaime; Fonseca Vivian; Fowler Michael; Frye Robert; Giles Thomas; Haffner Steven; Hollenberg Norman; Hsueh Willa; Law Ronald; Plutzky Jorge; Ratner Robert; Reusch Jane; Selwyn Andrew; Sowers James; Wyne Kathleen; Young Lawrence H
Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome.
Metabolic syndrome and related disorders 2005;3(2):147-73.
2005: Ruilope Luis M; Rosei Enrico Agabiti; Bakris George L; Mancia Giuseppe; Poulter Neil R; Taddei Stefano; Unger Thomas; Volpe Massimo; Waeber Bernard; Zannad Faiez
Angiotensin receptor blockers: therapeutic targets and cardiovascular protection.
Blood pressure 2005;14(4):196-209.
2005: Winer Nathaniel; Folker Amy; Murphy Julie A; Hung Elena; Bard Mara; Perkelvald Alexander; Sowers James R; Bakris George L
Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes.
Preventive cardiology 2005;8(2):87-92.
2004: Bakris George L; Bank Alan J; Kass David A; Neutel Joel M; Preston Richard A; Oparil Suzanne
Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.
American journal of hypertension 2004;17(12 Pt 2):23S-30S.
2004: Abbott Kevin C; Trespalacios Fernando C; Agodoa Lawrence Y; Taylor Allen J; Bakris George L
beta-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality.
Archives of internal medicine 2004;164(22):2465-71.
2004: Bakris George L
Implications of albuminuria on kidney disease progression.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(11 Suppl 3):18-22.
2004: Busby Douglas E; Bakris George L
Comparison of commonly used assays for the detection of microalbuminuria.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(11 Suppl 3):8-12.
2004: Bakris George L; Fonseca Vivian; Katholi Richard E; McGill Janet B; Messerli Franz H; Phillips Robert A; Raskin Philip; Wright Jackson T; Oakes Rosemary; Lukas Mary Ann; Anderson Karen M; Bell David S H;
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2004;292(18):2227-36.
2004: Bakris George
Inclusion of albuminuria in hypertension and heart guidelines.
Kidney international. Supplement 2004;(92):S124-5.
2004: Bakris George L; Gaxiola Efrain; Messerli Franz H; Mancia Giuseppe; Erdine Serap; Cooper-DeHoff Rhonda; Pepine Carl J;
Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study.
Hypertension 2004;44(5):637-42.
2004: Bakris George L
Clinical importance of microalbuminuria in diabetes and hypertension.
Current hypertension reports 2004;6(5):352-6.
2004: Jamerson Kenneth A; Bakris George L; Wun Chuan-Chuan; Dahlöf Björn; Lefkowitz Martin; Manfreda Sheryl; Pitt Bertram; Velazquez Eric J; Weber Michael A
Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.
American journal of hypertension 2004;17(9):793-801.
2004: McCullough Peter A; Bakris George L; Owen William F; Klassen Preston S; Califf Robert M
Slowing the progression of diabetic nephropathy and its cardiovascular consequences.
American heart journal 2004;148(2):243-51.
2004: Fox Jonathan C; Leight Kellie; Sutradhar Santosh C; Demopoulos Laura A; Gleim Gilbert W; Lewin Andrew J; Bakris George L
The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(8):437-42; quiz 443-4.
2004: Chrysant Steven G; Bakris George L
Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
American journal of hypertension 2004;17(7):590-6.
2004: Hart Peter D; Bakris George L
Hypertension control rates: time for translation of guidelines into clinical practice.
The American journal of medicine 2004;117(1):62-4.
2004: Bakris George L; Weir Matthew R; Secic Michelle; Campbell Brett; Weis-McNulty Annette
Differential effects of calcium antagonist subclasses on markers of nephropathy progression.
Kidney international 2004;65(6):1991-2002.
2004: Khosla Nitin; Hart Peter; Bakris George L
Management of hypertension in the cardiometabolic syndrome and diabetes.
Current diabetes reports 2004;4(3):199-205.
2004: Chua Dave C Y; Bakris George L
Is proteinuria a plausible target of therapy?
Current hypertension reports 2004;6(3):177-81.
2004: Bakris George
How to adjust ACE inhibitors and ARBs in diabetes?
Postgraduate medicine 2004;115(5):9-10.
2004: Davidson Mayer B; Bazargan Mohsen; Bakris George; Peters Harmel Anne; Campese Vito; Basta Emad
ImmunoDip: an improved screening method for microalbuminuria.
American journal of nephrology 2004;24(3):284-8.
2004: Bakris George L; Sowers James R
When does new onset diabetes resulting from antihypertensive therapy increase cardiovascular risk.
Hypertension 2004;43(5):941-2.
2004: Abbott Kevin; Basta Emad; Bakris George L
Blood pressure control and nephroprotection in diabetes.
Journal of clinical pharmacology 2004;44(4):431-8.
2004: Gashti Casey N; Bakris George L
The role of calcium antagonists in chronic kidney disease.
Current opinion in nephrology and hypertension 2004;13(2):155-61.
2004: Bakris George L
The importance of blood pressure control in the patient with diabetes.
The American journal of medicine 2004;116 Suppl 5A():30S-38S.
2004: Mangrum Amy J; Bakris George L
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues.
Seminars in nephrology 2004;24(2):168-75.
2004: Izhar Munavvar; Alausa Tunji; Folker Amy; Hung Elena; Bakris George L
Effects of COX inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and hispanics.
Hypertension 2004;43(3):573-7.
2004: Ruilope Luis M; Usan Luis; Segura Julián; Bakris George L
Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
Journal of hypertension 2004;22(1):217-22.
2004: Abbott Kevin C; Bakris George L
What have we learned from the current trials?
The Medical clinics of North America 2004;88(1):189-207.
2004: Chua Dave Y; Bakris George L
Clinical implications of blockade of the renin-angiotensin system in management of hypertension.
Contributions to nephrology 2004;143():105-16.
2004: Chua Dave Y; Bakris George L
Diabetes and chronic kidney disease: tragedy and challenge.
Blood purification 2004;22(1):130-5.
2003: Bakris George L
Hypertension and nephropathy.
The American journal of medicine 2003;115 Suppl 8A():49S-54S.
2003: Pepine Carl J; Handberg Eileen M; Cooper-DeHoff Rhonda M; Marks Ronald G; Kowey Peter; Messerli Franz H; Mancia Giuseppe; Cangiano José L; Garcia-Barreto David; Keltai Matyas; Erdine Serap; Bristol Heather A; Kolb H Robert; Bakris George L; Cohen Jerome D; Parmley William W;
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
JAMA : the journal of the American Medical Association 2003;290(21):2805-16.
2003: Chobanian Aram V; Bakris George L; Black Henry R; Cushman William C; Green Lee A; Izzo Joseph L; Jones Daniel W; Materson Barry J; Oparil Suzanne; Wright Jackson T; Roccella Edward J;
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
Hypertension 2003;42(6):1206-52.
2003: Garg Jay; Bakris George L
Are antihypertensive drugs used to maximally reduce cardiovascular risk in dialysis patients?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;42(6):1301-4.
2003: Abbott Kevin C; Bakris George L
Cardiology patient page. Kidney failure and cardiovascular disease.
Circulation 2003;108(16):e114-5.
2003: Eknoyan Garabed; Hostetter Thomas; Bakris George L; Hebert Lee; Levey Andrew S; Parving Hans-Henrik; Steffes Michael W; Toto Robert
Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;42(4):617-22.
2003: Weinberg Marc S; Kaperonis Nicholas; Bakris George L
How high should an ACE inhibitor or angiotensin receptor blocker be dosed in patients with diabetic nephropathy?
Current hypertension reports 2003;5(5):418-25.
2003: Weber Michael A; Bakris George L; Neutel Joel M; Davidai Giora; Giles Thomas D
Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blocker.
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(5):322-9.
2003: Bakris George L
Role for beta-blockers in the management of diabetic kidney disease.
American journal of hypertension 2003;16(9 Pt 2):7S-12S.
2003: Bakris George L
Who should be treated with combination therapy as initial treatment for hypertension?
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(4 Suppl 3):21-8.
2003: Bakris George L
Achieving blood pressure goals: is fixed-dose combination therapy the answer?
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(4 Suppl 3):2-3.
2003: Bakris George L; Weir Matthew R; Shanifar Shahnaz; Zhang Zhongxin; Douglas Janice; van Dijk David J; Brenner Barry M;
Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
Archives of internal medicine 2003;163(13):1555-65.
2003: Appel Lawrence J; Middleton John; Miller Edgar R; Lipkowitz Michael; Norris Keith; Agodoa Lawrence Y; Bakris George; Douglas Janice G; Charleston Jeanne; Gassman Jennifer; Greene Tom; Jamerson Kenneth; Kusek John W; Lewis Julia A; Phillips Robert A; Rostand Stephen G; Wright Jackson T
The rationale and design of the AASK cohort study.
Journal of the American Society of Nephrology : JASN 2003;14(7 Suppl 2):S166-72.
2003: Gassman Jennifer J; Greene Tom; Wright Jackson T; Agodoa Lawrence; Bakris George; Beck Gerald J; Douglas Janice; Jamerson Ken; Lewis Julia; Kutner Michael; Randall Otelio S; Wang Shin-Ru
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK).
Journal of the American Society of Nephrology : JASN 2003;14(7 Suppl 2):S154-65.
2003: Giles Thomas D; Bakris George L; Smith David H G; Davidai Giora; Weber Michael A
Defining the antihypertensive properties of the angiotensin receptor blocker telmisartan by a practice-based clinical trial.
American journal of hypertension 2003;16(6):460-6.
2003: Trespalacios Fernando C; Taylor Allen J; Agodoa Lawrence Y; Bakris George L; Abbott Kevin C
Heart failure as a cause for hospitalization in chronic dialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(6):1267-77.
2003: Bakris George L; Weir Matthew R;
Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches.
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(3):202-9.
2003: Bakris George L
The evolution of treatment guidelines for diabetic nephropathy. Strategies integrate JNC VI, more recent protocols.
Postgraduate medicine 2003;113(5):35-40, 43-4, 50.
2003: Chobanian Aram V; Bakris George L; Black Henry R; Cushman William C; Green Lee A; Izzo Joseph L; Jones Daniel W; Materson Barry J; Oparil Suzanne; Wright Jackson T; Roccella Edward J;
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
JAMA : the journal of the American Medical Association 2003;289(19):2560-72.
2003: Douglas Janice G; Bakris George L; Epstein Murray; Ferdinand Keith C; Ferrario Carlos; Flack John M; Jamerson Kenneth A; Jones Wendell E; Haywood Julian; Maxey Randall; Ofili Elizabeth O; Saunders Elijah; Schiffrin Ernesto L; Sica Domenic A; Sowers James R; Vidt Donald G;
Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.
Archives of internal medicine 2003;163(5):525-41.
2003: Bakris George
When to refer patients to a nephrologist?
Postgraduate medicine 2003;113(2):11.
2003: Bakris G; Viberti G; Weston W M; Heise M; Porter L E; Freed M I
Rosiglitazone reduces urinary albumin excretion in type II diabetes.
Journal of human hypertension 2003;17(1):7-12.
2003: Kaperonis Nicholas; Bakris George
Blood pressure, antihypertensive therapy and risk for renal injury in African-Americans.
Current opinion in nephrology and hypertension 2003;12(1):79-84.
2002: Garg Jay; Bakris George L
Treatment of hypertension in patients with renal disease.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2002;16(6):503-10.
2002: Bakris George L; Weir Matthew
ACE inhibitors and protection against kidney disease progression in patients with type 2 diabetes: what's the evidence.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(6):420-3.
2002: Wright Jackson T; Bakris George; Greene Tom; Agodoa Larry Y; Appel Lawrence J; Charleston Jeanne; Cheek DeAnna; Douglas-Baltimore Janice G; Gassman Jennifer; Glassock Richard; Hebert Lee; Jamerson Kenneth; Lewis Julia; Phillips Robert A; Toto Robert D; Middleton John P; Rostand Stephen G;
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
JAMA : the journal of the American Medical Association 2002;288(19):2421-31.
2002: Bakris George; Calhoun David; Egan Brent; Hellmann Christopher; Dolker Michael; Kingma Iris;
Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension.
Journal of hypertension 2002;20(11):2257-67.
2002: Sowers James R; Ferdinand Keith C; Bakris George L; Douglas Janice G
Hypertension-related disease in African Americans. Factors underlying disparities in illness and its outcome.
Postgraduate medicine 2002;112(4):24-6, 29-30, 33-4 passim.
2002: Bakris George L; Ferdinand Keith C; Douglas Janice G; Sowers James R
Optimal treatment of hypertension in African Americans. Reaching and maintaining target blood pressure goals.
Postgraduate medicine 2002;112(4):73-4, 77-80, 83-4.
2002: Douglas Janice G; Ferdinand Keith C; Bakris George L; Sowers James R
Barriers to blood pressure control in African Americans. Overcoming obstacles is challenging, but target goals can be attained.
Postgraduate medicine 2002;112(4):51-2, 55, 59-62 passim.
2002: Bakris George L
Hypertension and diabetes: family physicians' pivotal role.
American family physician 2002;66(7):1151-2.
2002: Bakris George
Comparison of telmisartan vs. valsartan in the treatment of mild to moderate hypertension using ambulatory blood pressure monitoring.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(4 Suppl 1):26-31.
2002: Bakris George L; Sowers James R
Microalbuminuria in diabetes: focus on cardiovascular and renal risk reduction.
Current diabetes reports 2002;2(3):258-62.
2002: Garg Jay; Bakris George L
Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetes.
Current hypertension reports 2002;4(3):185-90.
2002: Bakris George L; Mensah George A
Pathogenesis and clinical physiology of hypertension.
Cardiology clinics 2002;20(2):195-206, v.
2002: Moser Marvin; Bakris George L; Black Henry
Roundtable discussion: problems in the management of hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(3):207-13.
2002: Garg Jay; Messerli Adrian W; Bakris George L
Evaluation and treatment of patients with systemic hypertension.
Circulation 2002;105(21):2458-61.
2002: Russo Leileata M; Bakris George L; Comper Wayne D
Renal handling of albumin: a critical review of basic concepts and perspective.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(5):899-919.
2002: Bakris G L; Smith A C; Richardson D J; Hung E; Preston R; Goldberg R; Epstein M
Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study.
Journal of human hypertension 2002;16(3):185-91.
2002: Garg Jay P; Bakris George L
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.
Vascular medicine (London, England) 2002;7(1):35-43.
2002: Bakris George; Sica Dominic; Ram Venkata; Fagan Timothy; Vaitkus Paul T; Anders Robert J
A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
American journal of hypertension 2002;15(1 Pt 1):53-7.
2002: Sica Domenic A; Bakris George L
Type 2 diabetes: RENAAL and IDNT--the emergence of new treatment options.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(1):52-7.
2002: Abbott Kevin C; Bakris George L
Treatment of the diabetic patient: focus on cardiovascular and renal risk reduction.
Progress in brain research 2002;139():289-98.
2002: Hogan Thomas J; Elliott William J; Seto Arnold H; Bakris George L
Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation.
PharmacoEconomics 2002;20(1):37-47.
2001: Bakris G L
A practical approach to achieving recommended blood pressure goals in diabetic patients.
Archives of internal medicine 2001;161(22):2661-7.
2001: Basta E; Bakris G
Choices and goals in the treatment of the diabetic hypertensive patient.
Current hypertension reports 2001;3(5):387-91.
2001: Bakris G L
Angiotensin-converting enzyme inhibition to enhance vascular health--clinical and research models.
American journal of hypertension 2001;14(8 Pt 2):264S-269S.
2001: Bakris G L
Microalbuminuria: what is it? Why is it important? What should be done about it?
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(2):99-102.
2001: Bakris G L
Treatment of stage I hypertension and development of renal dysfunction.
Journal of human hypertension 2001;15(2):81-4.
2001: Bakris G; Gradman A; Reif M; Wofford M; Munger M; Harris S; Vendetti J; Michelson E L; Wang R;
Antihypertensive efficacy of candesartan in comparison to losartan: the CLAIM study.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(1):16-21.
2000: Bakris G L; Siomos M; Richardson D; Janssen I; Bolton W K; Hebert L; Agarwal R; Catanzaro D
ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group.
Kidney international 2000;58(5):2084-92.
2000: Bakris G L; Whelton P; Weir M; Mimran A; Keane W; Schiffrin E
The future of clinical trials in chronic renal disease: outcome of an NIH/FDA/Physician Specialist Conference. Evaluation of Clinical Trial Endpoints in Chronic Renal Disease Study Group.
Journal of clinical pharmacology 2000;40(8):815-25.
2000: Koshy S; Bakris G L
Therapeutic approaches to achieve desired blood pressure goals: focus on calcium channel blockers.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2000;14(3):295-301.
2000: Bakris G
Oral antidiabetic agents safe with renal disease?
Postgraduate medicine 2000;107(7):66.
2000: Bakris G L; Weir M R
Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?
Archives of internal medicine 2000;160(5):685-93.
2000: Weir M R; Maibach E W; Bakris G L; Black H R; Chawla P; Messerli F H; Neutel J M; Weber M A
Implications of a health lifestyle and medication analysis for improving hypertension control.
Archives of internal medicine 2000;160(4):481-90.
2000: Bakris G; Sowers J; Epstein M; Williams M
Hypertension in patients with diabetes. Why is aggressive treatment essential?
Postgraduate medicine 2000;107(2):53-6, 61-4.
1999: Bakris G L; Lass N A; Glock D
Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors.
Kidney international 1999;56(1):206-10.
1998: Bakris G L
The role of combination antihypertensive therapy and the progression of renal disease hypertension: looking toward the next millennium.
American journal of hypertension 1998;11(10):158S-162S.
1998: Bakris G L; Weir M R; DeQuattro V; McMahon F G
Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.
Kidney international 1998;54(4):1283-9.
1998: Villarosa I P; Bakris G L
The Appropriate Blood Pressure Control in Diabetes (ABCD) Trial.
Journal of human hypertension 1998;12(9):653-5.
1998: Smith A C; Toto R; Bakris G L
Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy.
Kidney international 1998;54(3):889-96.
1998: Bakris G L
Angiotensin II receptor blockers in hypertension and renal disease.
Hospital practice (1995) 1998;33(4):19-22.
1997: Tarif N; Bakris G L
Angiotensin II receptor blockade and progression of nondiabetic-mediated renal disease.
Kidney international. Supplement 1997;63():S67-70.
1997: Mangrum A; Bakris G L
Predictors of renal and cardiovascular mortality in patients with non-insulin-dependent diabetes: a brief overview of microalbuminuria and insulin resistance.
Journal of diabetes and its complications 1997;11(6):352-7.
1997: Bakris G L; Kusmirek S L; Smith A C; Gavras I; Gavras H
Calcium antagonism abolishes the antipressor action of vasopressin (V1) receptor antagonism.
American journal of hypertension 1997;10(10 Pt 1):1153-8.
1997: Bakris G L; Griffin K A; Picken M M; Bidani A K
Combined effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on renal injury.
Journal of hypertension 1997;15(10):1181-5.
1997: Silverman M; Bakris G L
Treatment of renal failure and blood pressure.
Current opinion in nephrology and hypertension 1997;6(3):237-42.
1997: Bakris G; White D
Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy.
Journal of human hypertension 1997;11(1):35-8.
1997: Bakris G L; Messerli F H
The Lanai Symposium: hypertensive patient profiles: approaches to management and disease prevention.
Journal of human hypertension 1997;11(1):7-8.
1996: Bakris G L; Weir M R
Salt intake and reductions in arterial pressure and proteinuria. Is there a direct link?
American journal of hypertension 1996;9(12 Pt 2):200S-206S.

Sign-in to see more